SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-034000
Filing Date
2023-03-17
Accepted
2023-03-17 17:15:07
Documents
12
Period of Report
2023-03-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239172d2_8k.htm   iXBRL 8-K 24416
  Complete submission text file 0001104659-23-034000.txt   199847

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krbp-20230314.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20230314_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20230314_pre.xml EX-101.PRE 22593
6 EXTRACTED XBRL INSTANCE DOCUMENT tm239172d2_8k_htm.xml XML 3703
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 23743793
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences